IL6 and metabolic syndrome: Various mediators and cytokines such as tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1), released by the accumulating inflammatory cells and adipocytes, may contribute to the development of metabolic syndrome, thus exacerbating the consequences of obesity3.